The curated database of hedge funds that publish investor letters. Research by geography, strategy, and schools of thought.
| # | Fund | Strategy | Style | Geography | AUM | Latest Letter |
|---|---|---|---|---|---|---|
The Davenport Value & Income Fund returned 3.17% in Q2 2026, underperforming the Russell 1000 Value Index's 13.87% return as semiconductor stocks dominated market gains with a 138% quarterly advance. The fund's best performers were Texas Instruments and Cisco, both benefiting from AI infrastructure spending, along with health insurers UnitedHealth and Elevance as the underwriting cycle improved. Energy holdings Exxon Mobil and Chevron detracted as oil prices fell 30% following reduced Iran tensions. Accenture lagged on concerns that AI efficiency gains may reduce billable consulting hours. The fund initiated positions in Abbott Laboratories and International Flavors & Fragrances at 16-17x earnings, below historical averages, with 2-2.6% dividend yields. Six holdings raised dividends, including Johnson & Johnson for the 64th consecutive year. Major banks increased dividends 10-12% after passing Federal Reserve stress tests. Management emphasizes the fund trades at a significant discount to the Russell 1000 Value while providing a 2.5% yield, maintaining commitment to value and income principles despite near-term underperformance versus momentum-driven technology stocks. The team views current market concentration in capital-intensive AI stocks as creating opportunity for patient, dividend-focused investors.
The Davenport Value & Income Fund maintains disciplined adherence to value investing and dividend income generation despite significant underperformance versus momentum-driven indices dominated by AI and semiconductor stocks in Q2 2026.
Management expects the current one-sided sentiment toward technology and AI to eventually normalize, though timing is uncertain. The fund will continue to prioritize companies that possess more capital than they need and return excess capital to shareholders via dividends and buybacks. The team views return on capital and return of capital as timeless investment principles that can benefit investors who stay true to them, particularly in an environment where many high-flying companies have become increasingly capital intensive.
As of Jul 28, 2026
The fund is managed by a highly experienced three-person team led by George L. Smith III, CFA, who serves as Chairman of the Investment Policy Committee and Managing Director with 27 years of investment experience and 24 years at Davenport. The team includes co-managers Jeff Omohundro, CFA, and Christopher G. Pearson, CFA, all bringing extensive expertise in equity management. Founded in 1983 as the first portfolio launched by Davenport Asset Management, the fund has established a long track record of disciplined investment management with strong historical performance including 17.0% annualized returns over three years.
Lead Portfolio Manager
Moderate Conviction Bullish
Market Conviction
The fund demonstrates moderate-to-high conviction through its willingness to significantly underperform benchmarks while maintaining disciplined adherence to its value and income mandate. Management explicitly states they will not alter their approach despite substantial opportunity cost, showing strong commitment to their investment philosophy. The letter names specific positions with clear theses: Texas Instruments benefiting from AI with improving free cash flow, health insurers experiencing underwriting cycle improvement, and new purchases Abbott and International Flavors & Fragrances at specific valuation multiples (16-17x earnings) below historical averages. However, the fund holds a diversified portfolio of 20+ positions based on the top ten holdings representing roughly 28% of assets, which prevents a higher conviction score. The hedged language around Accenture (acknowledging change while viewing it as inexpensive) and the emphasis on patience rather than aggressive positioning also moderates the conviction assessment. The score reflects strong philosophical conviction but moderate portfolio concentration.
Growth Outlook
The letter expresses cautious optimism tempered by significant geopolitical risks. While managers see opportunities in current volatility and mention potential relief rallies, they acknowledge substantial headwinds from the Iran conflict, higher oil prices, and AI disruption concerns affecting multiple sectors.
Risk Appetite
The fund maintained a balanced approach, trimming energy positions into strength while adding new positions in infrastructure and cyclical names. This suggests a measured risk appetite - neither aggressive deployment nor defensive positioning, but selective capital allocation based on opportunities.
Capital Deployment
The fund initiated two new positions (Abbott Laboratories and International Flavors & Fragrances) during the quarter while making no full exits, indicating modest net deployment activity. However, no cash level changes are disclosed, and the letter provides no indication of meaningful reduction in cash balances or aggressive scaling of positions. The new purchases appear to be selective additions at attractive valuations rather than broad-based deployment. The fund also trimmed some winners during the quarter based on references in other fund letters, suggesting capital rotation rather than net new capital deployment. The overall tone emphasizes patience and discipline rather than urgency to put capital to work. The modest positive score reflects the two new initiations, but the absence of cash data and the cautious forward guidance prevent a higher deployment score.
Forward Guidance
Managers express confidence in their approach of capitalizing on short-term market inefficiencies while exercising long-term patience. They view sector rotation as creating opportunities and maintain a constructive stance on their positioning, suggesting mild optimism about future deployment.
Language Signal
The letter contains balanced directional language with modest bearish bias. Risk-oriented language includes references to one-sided sentiment, concentration risk, increasing capital intensity, reliance on capital markets funding, and the difficulty of safe navigation. However, positive language appears in discussions of companies that have turned the corner (health insurers, Texas Instruments, Cisco), improving underwriting cycles, attractive valuations on new purchases, and long dividend track records as evidence of good businesses. The net balance tilts slightly negative given the emphasis on market concentration concerns and the defensive framing of the fund's positioning, but the letter is not dominated by bearish warnings. The tone is more cautious and contrarian than overtly negative.
Perceived Risk
Managers identify multiple significant risks including geopolitical conflict in Iran, higher oil and gasoline prices weighing on consumers, upward pressure on inflation and interest rates, supply chain disruptions, and AI disruption concerns. The detailed discussion of these macro and sector-specific risks indicates elevated risk perception.
Opportunity Density
Management views the opportunity set as selective rather than abundant. The letter emphasizes that many areas of the market have languished while AI stocks have dominated, with value-oriented areas coming with significant opportunity cost. The phrase 'it just doesn't seem to matter how cheap many of these stocks get – they simply can't garner any interest' suggests frustration with limited opportunities meeting the fund's criteria. However, the fund did identify two new attractive purchases (Abbott and International Flavors & Fragrances) at below-average valuations, indicating opportunities exist for patient, disciplined investors. The characterization of the market as having a casino attached to a church suggests management sees more speculation than genuine investment opportunities. The opportunity density is neither abundant nor severely constrained, but requires selectivity and patience to find compelling ideas that fit the fund's value and income mandate.
Time Horizon
The fund demonstrates a multi-year investment horizon with emphasis on patience and long-term compounding. Management highlights dividend aristocrats with 49-64 consecutive years of dividend increases as evidence of their focus on durable, long-term business quality. The letter emphasizes return on capital and return of capital as timeless investment principles, suggesting a patient approach unconcerned with near-term performance. The willingness to significantly underperform benchmarks while maintaining discipline indicates comfort with multi-year thesis development. New purchases Abbott and International Flavors & Fragrances are framed around sustainable mid-to-high single digit growth and margin expansion over the foreseeable future rather than near-term catalysts. However, the fund does discuss quarterly underwriting cycle improvements and recent dividend increases, indicating some attention to nearer-term developments. The time horizon is clearly multi-year but not explicitly permanent capital or decade-plus, placing it in the 2-5 year range typical of active equity strategies with long-term orientation.
Top Conviction Themes
Key Catalysts
Every insight in this database connects to the original source. Read the actual thesis, see the actual concerns, and make your own call.
Buyside Digest has no business relationship, partnership, agency, sponsorship, endorsement, or affiliation with The Davenport Value & Income Fund or any other manager whose content appears on the Service, except where expressly stated. We do not receive Manager Content directly from managers in most cases; content is collected from publicly available sources. Managers have not necessarily reviewed, approved, authorized, or endorsed our display of their content, our editorial commentary, our metadata extraction, or our classifications. Use of a manager’s name is for accurate attribution and identification purposes only, under principles of nominative fair use.
Buyside Digest does not independently verify the regulatory status, registrations, licensing, qualifications, credentials, or professional standing of managers whose content appears on the Service. We do not represent that managers are properly registered with applicable regulatory bodies, that their content complies with applicable securities laws, or that their performance representations are accurate. Inclusion of a manager in our database is based on the publicly available nature of their content, not on our verification of their regulatory status or content compliance. Users are responsible for conducting their own due diligence on any manager.
Performance data, returns, assets under management (“AUM”), and similar figures displayed on this page are sourced from publicly available manager communications (including investor letters), public filings, or other third-party sources. Buyside Digest does not independently verify performance figures, calculate returns, or audit manager-reported data. Such figures: May be selectively reported by the manager; May use non-standard calculation methodologies; May not reflect fees, expenses, taxes, or other costs; May be inconsistent across reporting periods; May be outdated. Past performance is not indicative of future results. Performance figures should not be relied upon for investment decisions without independent verification. Users should request audited performance data directly from the manager and conduct their own due diligence.